Replies to post #2344 on Revance Therapeutics Inc (RVNC)

[DewDiligence]

RVNC fully-diluted shares @2/17/22=88.3M—a decrease of 1.1M shares since 10/28/21 (#msg-166764546).

As enumerated on page 92 of the 2021 10-K (https://www.sec.gov/ix?doc=/Archives/edgar/data/0001479290/000147929022000034/rvnc-20211231.htm#id2932a2a7f8d430d9256a3571a3eea70_232 ), the 89.4M figure above consists of: 71.5 basic shares; 4.7M options; 3.2M shares of (already issued) unvested restricted stock awards; and 8.9M shares deriving from the convertible debt issued in Feb 2020.

(Excluding the shares derived from the convertible debt, fully-diluted shares at 2/17/22 were 79.4M.)